2,204
Views
4
CrossRef citations to date
0
Altmetric
Drug Evaluations

Evaluation of idursulfase for the treatment of mucopolysaccharidosis II (Hunter syndrome)

, MD PhD
Pages 89-98 | Published online: 17 Dec 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

David AH Whiteman & Alan Kimura. (2017) Development of idursulfase therapy for mucopolysaccharidosis type II (Hunter syndrome): the past, the present and the future. Drug Design, Development and Therapy 11, pages 2467-2480.
Read now

Articles from other publishers (3)

Marialaura Marchetti, Serena Faggiano & Andrea Mozzarelli. (2022) Enzyme Replacement Therapy for Genetic Disorders Associated with Enzyme Deficiency. Current Medicinal Chemistry 29:3, pages 489-525.
Crossref
Shifaza Mohamed, Qi Qi He, Arti A. Singh & Vito Ferro. 2020. 71 117 .
Yo Kyung Chung, Young Bae Sohn, Jong Mun Sohn, Jieun Lee, Mi Sun Chang, Younghee Kwun, Chi Hwa Kim, Jin Young Lee, Yeon Joo Yook, Ah-Ra Ko & Dong-Kyu Jin. (2014) A biochemical and physicochemical comparison of two recombinant enzymes used for enzyme replacement therapies of hunter syndrome. Glycoconjugate Journal 31:4, pages 309-315.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.